U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805461) titled 'PanTheR Registry Trial' on Jan. 10.
Brief Summary: This study is a multicenter, observational, post-marketing, registry study designed to track the safety and performance of the RenovoCath(R) device and assess survival outcomes in patients diagnosed with solid tumors who are treated with localized intra-arterial (IA) delivery of therapeutic agents to solid tumors using the RenovoCath(R) catheter.
Study Start Date: Feb. 28
Study Type: OBSERVATIONAL
Condition:
Solid Tumors
Intervention:
DEVICE: RenovoCath(R)
Intra-arterial catheter delivery of chemotherapy agents for the collection of real-world data.
Recruitment Status: NOT_YE...